BENTSUR RON (Chairman & CEO) purchased 0.1% of their position (5K shares) of NUVECTIS PHARMA, INC. on the open market
Open‑market purchase worth $28.6K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 11/6/2025ACC: 0001104659-25-107423
DirectorOfficer· Chairman & CEO
Since Feb 2022
+5K
Net shares
Net buyer
$28.6K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
5K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+5K
Price / share
$5.72
Trade value
$28.60K
% of position
0.1%
11/5/2025
3.52M→3.53M
Total
Net shares
+5K
Net value
$28.60K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/5/2025 | P · Purchase | +5K | $5.72 | $28.60K | 0.1% | 3.52M | 3.53M |
| Total | +5K | $28.60K | ||||||
Derivative Transactions0
No derivative transactions reported